Health IT

Healthcare information (HIT) systems are designed to connect all the elements together for patient data, reports, medical imaging, billing, electronic medical record (EMR), hospital information system (HIS), PACS, cardiology information systems (CVIS), enterprise image systems, artificial intelligence (AI) applications, analytics, patient monitors, remote monitoring systems, inventory management, the hospital internet of things (IOT), cloud or onsite archive/storage, and cybersecurity.

RSS icon
Thumbnail

Part 2, Q&A with next HIMSS CEO Hal Wolf: Health IT industry shouldn’t fear AI

Embracing artificial intelligence (AI) technology is “a necessity” for the health IT industry, according to Harold “Hal” Wolf III, the next president and CEO of the Healthcare Information and Management Systems Society (HIMSS).

Thumbnail

Ransomware attacks in healthcare industry increases by 133%

The healthcare industry has fought an uphill battle against hackers in 2017—and it shows in the latest Beazley Breach Insights report. The report, conducted by the cyber and data breach response insurance firm, found the rate of ransomware attacks had increased by 50 percent in the first quarter of 2017, with demands up 133 percent.

Thumbnail

Q&A with next HIMSS CEO Hal Wolf: 'Absolute gap' between IT vendors, providers

It’s been quite a long time since anyone except Stephen Lieber was been president and CEO of The Healthcare Information and Management Systems Society (HIMSS), but he’ll soon be handing over the reins after 17 years to Harold “Hal” Wolf III, an alum of Kaiser Permanente and the Chartis Group as well as a HIMSS board member.

Bipartisan bill aims to hold device vendors accountable for security

Cybersecurity remains a hot topic in healthcare as hacking and ransomware attacks are becoming commonplace. In an effort to improve security measures, a bipartisan group of senators have introduced legislation directly targeting the vulnerabilities in devices that have the potential to be breached.

Lock it down: 11 findings from cybersecurity survey of healthcare execs

Cyber security is at the top of the list for improvement in many healthcare organizations due to the uptake ransomware attacks in the recent month. The recently published 2017 KPMG/Forbes Insights CyberSecurity Survey outlines on the current landscape of cyber security, technology and strategies in ensuring patient data remains safe while also showcasing where the industry lacks in protecting electronic information.

Better technology, strategy top avenues to improving cybersecurity

KPMG has released its 2017 Cyber Healthcare & Life Sciences Survey, outlining current cybersecurity measures and threats.

HHS introduces tool to provide information on data breaches

The HHS Office for Civil Rights (OCR) has introduced a revised HIPAA Breach Reporting Tool (HBRT) that gives individuals information to improve identification of data breaches and help them understand how they are investigated and resolved.

Hacking victims spent more than $25M in ransom demands

Ransomware has become an increasingly familiar method of cyberattacking healthcare organizations and patient data. In the past two years, hacking victims have paid more than $25 million in ransom, according to a study by Google.

Displaying 465 - 472 of 3875

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.